Biology Enzyme Unit

Réussis tes devoirs et examens dès maintenant avec Quizwiz!

Define enzyme denaturation and describe ways in which it occurs

Denaturation is changing the structure of an enzyme (or other protein) so it can no longer carry out its function. Change in pH and/or temperature stops the enzyme's functions

Explain the effects of temperature, pH and substrate concentration on enzyme activity.

Enzyme activity increases with an increase in temperature and usually doubles with every 10 degrees rise. This is due to the molecules moving faster and colliding more often together. However at a certain point the temperature gets to high and the enzymes denature and stop functioning. This is due to the heat causing vibrations within the enzyme destroying its structure by breaking the bonds in the enzyme. Enzymes usually have an optimum pH at which they work most efficiently. As the pH diverges from the optimum, enzyme activity decreases. Both acid and alkali environments can denature enzymes. Enzyme activity increases with an increase in substrate concentration as there are more random collisions between the substrate and the active site. However, at some point, all the active sites are taken up and so increasing the substrate concentration will have no more effect on enzyme activity. As long as there are active sites available, an increase in substrate concentration will lead to an increase in enzyme activity.

Explain competitive inhibition, with reference to one example

Enzyme inhibitors are substances which inhibit enzyme activity. There are competitive enzyme inhibitors and non-competitive inhibitors. Competitive Inhibitors These are structurally similar to the substrate of the enzyme and bind to the active site. This means that when a competitive inhibitor binds to the active site of an enzyme, it prevents the substrate from binding to the active site. Only once the inhibitor has been released from the active site can the substrate bind. The inhibitor is called a competitive inhibitor as it competes with the substrate for the active site. The effects of a competitive inhibitor can be reduced by increasing the substrate concentration. More substrate would successfully bind to the active site than inhibitor and therefore reducing the effect of the inhibition. The maximum rate of reaction or a level very close to the maximum rate of reaction can be reached. An example of a competitive inhibitor is malonate. Malonate is structurally similar to the substrate succinate. Succinate is found in the Krebs cycle of aerobic respiration and binds to the active site of the dehydrogenase enzyme. Malonate can compete with succinate for the active site and in doing so it can prevent succinate from binding.

Explain non-competitive inhibition, with reference to one example

Enzyme inhibitors are substances which inhibit enzyme activity. There are competitive enzyme inhibitors and non-competitive inhibitors. Non-Competitive Inhibition These are not similar to the substrate and they do not bind to the active site of the enzyme. Instead they bind to a different site on the enzyme and change the conformation of the active site. The substrate may still be able to bind to the active site however the enzyme is not able to catalyze the reaction or can only do so at a slower rate. In the presence of a non-competitive inhibitor, increasing the substrate concentration cannot prevent the inhibitor from binding to the enzyme as the two bind to different sites. Therefore, no matter how high the concentration of substrate is, some of the enzymes will still be inhibited. The maximum rate of reaction will always be lower in the presence of a non-competitive inhibitor. An example of a non-competitive inhibitor is ATP. When ATP accumulates it binds to a site other than the active site on the enzyme phosphofructokinase. In doing so it changes the enzyme conformation and lowers the rate of reaction so that less ATP is produced.

Define enzyme and active site

Enzymes: Globular proteins which act as catalysts of chemical reactions. Active site: Region on the surface of an enzyme to which substrates bind and which catalyses a chemical reaction involving the substrates.

Describe the induced-fit model for enzymes (extension of lock and key model)

Initially the substrate does not fit perfectly into the active site of the enzyme. When the substrate binds to the active site, this changes the shape of the active site and only then does it perfectly fit the substrate. As the substrate binds it changes the shape of the active site and this weakens the bonds in the substrate and therefore reduces the activation energy. This model is a more precise version of the lock and key one. The reason for this is that it explains why some enzymes can bind to many different substrates. If the shape of the active site changes when a substrate binds, this allows many different but similar substrates to bind to the one enzyme.

Explain the control of metabolic pathways by end-product inhibition, including the role of allosteric sites.

Metabolic pathways are made up of many chemical reactions and these reactions are catalysed by enzymes. Often, the product of the last reaction in the pathway inhibits the enzyme that catalyses the first reaction of the pathway. This is called end-product inhibition and it involves non-competitive inhibitors. The product of the last reaction of the metabolic pathway will bind to a site other than the active site of the enzyme that catalyses the first reaction. This site is called the allosteric site. When it binds to the allosteric site it acts as non-competitive inhibitor and changes the conformation of the active site. Therefore, it makes the binding of the substrate to the enzyme unlikely. Once the inhibitor is released from the allosteric site, the active site returns to its original conformation and the substrate is able to bind again. There is a clear advantage in using end-product inhibition for controlling metabolic pathways. When there is an excess of end-product, the whole metabolic pathway is shut down as the end product inhibits the first enzyme of the pathway. Therefore less of the end product gets produced and by inhibiting the first enzyme it also prevents the formation of intermediates. When the levels of the end product decrease, the enzymes start to work again and the metabolic pathway is switched on.

State that metabolic pathways consist of chains and cycles of enzyme- catalyzed reactions.

Metabolic pathways consist of chains and cycles of enzyme-catalyzed reactions.

Explain that enzymes lower the activation energy of the chemical reactions that they catalyze (and be able to identify this effect on a graph)

Reactants of a chemical reaction need to gain energy before they can undergo the reaction. This required energy is called the activation energy of the reaction and it is needed to break bonds within the reactants. At a later stage in the reaction energy will be released as new bonds form. The majority of biological reactions are exothermic. In exothermic reactions the energy released by the new bonds formed is greater than the activation energy. In other words, the reaction releases energy. Enzymes make it easier for reactions to occur by decreasing the activation energy required in the reactions that they catalyze.

Explain enzyme-substrate specificity.

The active site of an enzyme is very specific to its substrates as it has a very precise shape. This results in enzymes being able to catalyze only certain reactions as only a small number of substrates fit in the active site. This is called enzyme-substrate specificity. For a substrate to bind to the active site of an enzyme it must fit in the active site and be chemically attracted to it. This makes the enzyme very specific to it's substrate. The enzyme-substrate complex can be compared to a lock and key, where the enzyme is the lock and the substrate is the key.


Ensembles d'études connexes

3 - (Vocab) Legal Concepts of the Insurance Contract

View Set

Topic 3: Translation of Foreign Currency Financial Statements

View Set

Principles of Personal Health Final Exam

View Set

3rd Quarter World Geography Ch.14-18

View Set

PrepU 1136 Chapter 48: Management of Patients with Kidney Disorders

View Set